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a b s t r a c t
This study analyzed the effects of overground walking training at ventilatory threshold (VT)
velocity on glycaemic control, body composition, physical fitness and lipid profile in DM2
women. Nineteen sedentary patients were randomly assigned to a control group (CG; n = 10,
55.9  2.2 years) or a trained group (TG; n = 9, 53.4  2.3 years). Both groups were subjected to
anthropometric measures, a 12-h fasting blood sampling and a graded treadmill exercise
test at baseline and after a 12-week period, during which TG followed a training program
involving overground walking at VT velocity for 20–60 min/session three times/week.
Significant group  time interactions (P < 0.05) in glycated hemoglobin (HbA1c), body mass,
body mass index (BMI), peak oxygen uptake (VO2peak) and exercise duration were observed
as effects of training exercise, whereas intervention did not induced significant changes
(P > 0.05) in fasting blood glucose, submaximal fitness parameters and lipid profile. Our
results suggest that overground walking training at VT velocity improves long term gly-
caemic control, body composition and exercise capacity, attesting for the relevance of this
parameter as an effective strategy for the exercise intensity prescription in DM2 population.
# 2011 Elsevier Ireland Ltd. 
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Glycaemic control is a fundamental component in the
management of type 2 diabetes mellitus (DM2) and its
complications [1,2], with convincing evidence showing physi-
cal training to be an effective strategy for this purpose [3–5]
since it increases both glucose transport and skeletal muscle
insulin sensitivity [6].
In this framework, walking has been considered a safe,
accessible and convenient exercise type for individuals with
DM2 without peripheral neuropathy. Given the familiar* Corresponding author at: Rua Oscar Ferreira de Carvalho, 41, CEP 13
E-mail address: taisa.belli@gmail.com (T. Belli).
0168-8227      # 2011 Elsevier Ireland Ltd. 
doi:10.1016/j.diabres.2011.05.007
  Open access under the Elsevier OA licenspattern of movement, walking exercise is easily added into
the daily physical activity routine of a patient with DM2 [7,8].
Furthermore, this type of exercise involves large skeletal
muscle mass, which plays a major role in peripheral glucose
uptake [9], thus triggering more effective improvement in
glycaemic homeostasis [10].
In addition to the type of exercise, other key components
(i.e., volume, frequency and intensity) must be considered in
training programs that intend to maximize health benefits
while minimizing risks in DM2 subjects, with special attention
being devoted to the exercise intensity [11–15]. In a meta-
analysis by Boule´ et al. [16], reductions in glycated hemoglobin690-000, Vila Vendramini, Descalvado, Sa˜o Paulo, Brazil.
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by exercise intensity than volume. Yet, although current
position statements from different world leading organiza-
tions [17–19] provide exercise intensity recommendations for
such population, these suggestions should be viewed with
caution given the wide range of moderate and vigorous
intensities based on percentages of maximal oxygen con-
sumption (VO2max) (40–59 and 60–84%) and/or maximal heart
rate (HRmax) (50–69 and 70–89%). It is well known that
exercising at a given percentage of VO2max or HRmax can elicit
different physiological responses for different individuals and
that submaximal parameters such as lactate or gas exchange
thresholds are better markers of the relative stress induced by
exercise [20].
Regardless of the controversy about its physiological
background [21], ventilatory threshold (VT), or the exercise
intensity above which ventilation begins to increase dispro-
portionately relative to oxygen uptake, has been considered a
direct, simple and useful parameter for optimal exercise
intensity prescription in DM2 patients [22–24]. While acute
exercise at VT reduces plasma glucose [25], training at this
intensity improves both the aerobic capacity and the cost-
effectiveness of treatment [26]. Moreover, Belli et al. [24]
showed the feasibility of VT determination during graded
treadmill test in women with DM2 without complications. In
spite of this, in most studies adopting walking exercise for
DM2 patients, intensity was either subjective [7,27,28] or based
on %HRmax [8,11,29–31].
Although VT accessed in a graded exercise test can be
expressed in both performance (i.e., power or velocity) and
physiological (i.e., %VO2max and %HRmax) terms [24], heart rate
(HR) at VT has been the preferred parameter for exercise
prescription in clinical settings [20,26]. However, despite the
increasing availability of portable monitors, continuous HR
assessment during training sessions is not without limitations
[32] and can be quite complex due to technical and learning
reasons. Alternatively, intensity control by means of velocity in
cyclic activities such as running and walking is very practical in
field settings, where subjects are commonly aware about
covering known distances in particular times. Yet, the
effectiveness of training overground at VT velocities derived
from treadmill tests in patients with DM2 remains to be
investigated. Thus, the purposes of this study were to assess the
effects of supervised overground walking training at ventilatory
threshold velocity on HbA1c, blood glucose, body composition,
physical fitness and lipid profile in type 2 diabetic women.
2. Materials and methods
2.1. Subjects
After approval by the Sa˜o Carlos Federal University Ethics
Committee for Human Research (no 034/04), 24 sedentary
middle-aged women with DM2 diagnosis [33] were recruited
from local health facilities and signed an informed consent
volunteering to take part in this investigation. All of them were
housewives, non-smokers and not engaged in regular exercise
practice, with current physical activity <1 h/week. Patients
were included in the study if their diabetes was treated by diet(n = 5) or oral agents (sulphonylurea, n = 6; metformin, n = 3;
and sulphonylurea + metformin, n = 10), but not if they were
treated with insulin given the tendency of an advanced
disease state in this case. Absence of long term complications
(retinopathy, microalbuminuria, nephropathy, peripheral and
autonomic neuropathy) as well as blood pressure greater than
160/95 mmHg were confirmed by clinical history, clinical
examination and laboratory tests. After a blinded randomiza-
tion by means of computer-generated random numbers
subjects were allocated in a control (CG) or a trained group
(TG), each one with 12 volunteers. Five of the 24 women
initially enrolled in the study were not able to conclude the
experimental protocol (2 from CG and 3 from TG) due to family
responsibilities (n = 3), thrombosis (n = 1) and spinal disc
herniation (n = 1), being these last events not attributed to
the study procedures. Therefore, our final sample was
composed by 10 and 9 subjects in the CG and TG, respectively.
No significant differences were found between groups for age
(55.9  2.2 vs 53.4  2.3 years, P = 0.48), height (155.0  1.6 vs
152.0  2.4 cm, P = 0.30) and disease time (3.7  0.8 vs 4.4  1.2
years, P = 0.71).
2.2. Experimental procedures
Using a longitudinal approach, all patients were submitted to
anthropometric measurements, a 12-h fasting blood sam-
pling, dietary evaluation and a graded exercise test on a
motorized treadmill at baseline and after a 12-week period.
Exercise test (TG only) and dietary evaluation (TG and CG) were
also performed at the 6th week. Subjects from the trained
group were evaluated 48–72 h after the last training session in
order to avoid residual influence of acute exercise.
2.3. Anthropometry
Height was accessed using a calibrated stadiometer (Filiz-
zola1, Brazil), while body mass and body composition
including percent body fat, fat and fat free mass, were
determined using a bioelectric impedance system with the
electrodes in contact with soles and heels of both feet (Tanita
Body Composition Analyzer TBF-310) [34]. Measurements
were performed in a quiet environment after a 12-h overnight
fast, being the subjects in the standing position without shoes
and using light clothes. Body mass index (BMI) was calculated
as body mass divided by squared height (kg/m2). Waist
circumferences were taken at narrowest circumference
between the lowest rib and the iliac crest by a single trained
evaluator using an inextensible metallic tape (Sanny1, Brazil)
placed directly on the skin, perpendicularly to the long axis of
the body and horizontally to the floor at the end of normal
expiration. For this purpose, subjects stood with feet together,
looking straight ahead with the arms hanging by the side of
the body [35]. Average values from two measurements were
considered.
2.4. Blood analysis
Following anthropometrical measures, 4 mL blood samples
were taken from subject’s antecubital vein into tubes (Vacu-
ette, Greiner Bio-One) with coagulation enhancer for posterior
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cholesterol, high density lipoprotein cholesterol (HDLC) and
triglycerides were determined by enzymatic-colorimetric
procedures (Laborlab1) using a spectrophotometer (VERSA-
Max1 microplate reader). Low density lipoprotein cholesterol
(LDLC) was determined using Friedwald’s equation for
triglycerides < 400 mg/dL. Additional 2 mL blood samples
were taken in tubes containing EDTA for HbA1c determination
using high-performance liquid chromatography (BioRad Dia-
STAT Analyzer1).
2.5. Dietary evaluation
For dietary evaluation, a 1-day food record was adopted in a
face to face interview conducted by an experienced dietitian.
Thereafter, records were analyzed using the ‘‘Nutrition
Support Program’’ software from the Escola Paulista de
Medicina–EPM (DIS-EPM, version 2.5a, UNIFESP, Brazil). It
was recommended a dietary education according to the
American Diabetes Association (ADA) position statement
[36] to all subjects to minimize dietary variability among
groups.
2.6. Graded exercise tests
After a familiarization session, graded exercise tests were
conducted using a previously described protocol [24] on a
treadmill (Moviment – LX-160, Brazil) without inclination.
Initial velocity was set at 1 km/h and increased by 1 km/h
every 2 min until voluntary exhaustion. During exercise, 20 s
average ventilation (VE), oxygen uptake (VO2) and carbon
dioxide production (VCO2) were monitored with subjects using
a nose clip and breathing into a mouthpiece (VO2000 Gas
Analyzer, MedGraphics, USA). The system was automatically
calibrated before each test and subjects were allowed to lightly
rest their hands on the treadmill bar during exercise to
maintain their balance. The highest VO2 attained during the
test was taken as the peak oxygen uptake (VO2peak). VT was
assessed by two independent investigators through VE/VO2
increase without a concomitant rise in VE/VCO2 [37]. After
20 min sitting rest preceding the exercise test, participants
had assessed their blood pressure by the auscultatory method
using an aneroid sphygmomanometer (Tycos, USA1) and a
stethoscope (Becton Dickinson, USA1). Furthermore, blood
pressure and heart rate (Polar S810, Polar Electro Oy, Finland1)
were measured at the end of each stage for safety reasons
during the test.
2.7. Training protocol
Women from TG were subjected to a 12-week walking training
program, which was performed in a flat 350 m outdoor track at
the individual VT velocity, three times a week (Monday,
Wednesday and Friday). All training sessions were supervised
and performed between 8:00 and 10:00 a.m. Stretching
exercises involving main muscle groups of upper and lower
limbs were performed before and after walking and individual
velocities were controlled by the first author during all training
sessions. For this purpose, sonorous signals were provided in
order to drive subjects to pass by marks placed 50 m apart inthe track in pre-determined times. After a familiarization
session prior to the first training bout, all subjects were able to
keep the prescribed velocity using this procedure within few
minutes, which has been previously adopted in field rehabili-
tation [38]. In the first week sessions lasted 20 min, being
duration increased by 10 min/week until 60 min at the 5th
week. This duration was kept until the end of training period.
A graded exercise test was carried out at the end of the 6th
week in order to adjust training speeds. Furthermore, in the
last training session of each two weeks, pre and post exercise
fingertip blood samples were taken in order to verify the acute
effects of the bout and assure that blood glucose (Optimum –
Medisense Product, Abbott Lab1) was kept in the safe range
suggested by ADA [39]. Volunteers from the CG continued their
normal lives without any systematic exercise during the
experimental protocol.
2.8. Statistical analysis
Statistical analysis was carried out using a statistical software
package (Statistic 7.0, Statsoft, Tulsa, USA). Mean and
standard error of mean (SEM) were calculated for all studied
variables. Normal distribution and homogeneity of the data
were verified by the Shapiro-Wilk and Levene’s tests,
respectively, and before using parametric analysis blood
glucose, triglycerides, maximal and submaximal velocities
were log transformed. Group comparisons at baseline were
carried out using unpaired t tests. Two-way 2  2 (group
 time) mixed analysis of variances (ANOVAs) were used to
investigate main effects and group  time interactions.
Dietary parameters were analyzed by means of 2  3 (group
 time) mixed ANOVAs, being Greenhouse-Geisser correction
applied if violation of sphericity was pointed by Mauchly’s
test. Unequal n Tukey post hoc test was performed when
appropriate. Statistical significance was set at P < 0.05 in all
cases.
3. Results
No significant differences (P > 0.05) were found between
trained and control groups for any studied variable at
baseline (Tables 1 and 2, Fig. 1), and high attendance to
the supervised training program was observed for the TG,
with volunteers performing 92  2% of 36 offered sessions.
Capillary blood glucose significantly decreased (P < 0.01)
after all selected bouts in this group, being averaged pre
and post exercise values respectively 162  8 vs 118  7 mg/
dL. No significant changes (P > 0.05) were found in fasting
blood glucose before and after experimental period (TG:
119  9 and 110  8 mg/dL; CG: 132  16 and 142  20 mg/dL).
On the other hand, while CG showed similar HbA1c levels
after training, a pronounced 11.6% decrease was found in TG,
leading to a significant (P < 0.05) group  time interaction
(Fig. 1).
Anthropometric measures, lipid profile and resting blood
pressure at baseline and after the 12-week period for both
groups are presented in Table 1. Greater reductions in body
mass and BMI were found in TG after the experimental period
and waist circumference increased in CG, being group  time
Table 1 – Anthropometric measures, lipid profile and resting blood pressure for trained group (TG) and control group (CG)
at baseline and after 12-weeks.
TG (n = 9) CG (n = 10) ANOVA P-value
Baseline 12-Weeks Baseline 12-Weeks Group Time Interaction
Body mass (kg) 75.0  6.1 72.5  5.9 71.8  4.2 71.4  4.2 0.77 <0.01 <0.01
Body mass index (kg.m2) 32.2  2.0 31.1  1.9 29.9  1.8 29.8  1.8 0.51 <0.01 <0.01
Fat-free mass (kg) 44.4  1.9 45.4  2.8 44.5  1.4 45.2  1.5 0.99 0.11 0.77
Fat mass (kg) 30.6  4.2 27.2  3.4 27.5  2.8 26.2  2.8 0.66 <0.01 0.06
Body fat (%) 39.5  2.4 36.6  1.9 37.3  1.9 35.7  2.2 0.61 <0.01 0.27
Waist (cm) 100.8  3.3 100.7  3.5 101.1  4.1 103.1  4.1 0.81 0.03 0.01
Total cholesterol (mg/dL) 202.1  10.7 184.8  11.3 233.4  19.5 202.9  15.1 0.23 <0.01 0.39
HDLC (mg/dL) 34.3  2.3 42.0  2.9 33.0  2.5 52.3  4.8 0.29 <0.01 0.02
LDLC (mg/dL) 141.9  11.7 109.9  12.9 169.9  18.2 119.3  10.9 0.39 <0.01 0.16
Triglycerides (mg/dL) 179.3  42.6 164.3  23.3 191.6  54.3 156.7  19.6 0.91 0.77 0.85
Resting SBP (mmHg) 130.0  6.9 117.0  9.4 138.0  4.5 130.0  8.4 0.24 0.07 0.68
Resting DBP (mmHg) 83.6  3.8 77.0  4.7 84.4  3.3 81.0  3.9 0.56 0.17 0.58
HDLC: high density lipoprotein cholesterol, LDLC: low density lipoprotein cholesterol, SBP: systolic blood pressure, DBP: diastolic blood
pressure.
Table 2 – Fitness parameters for trained group (TG) and control group (CG) at baseline and after 12-weeks.
TG (n = 8) CG (n = 9) ANOVA P-value
Baseline 12-Weeks Baseline 12-Weeks Group Time Interaction
Peak velocity (km. h1) 6.2  0.3 8.0  0.4 6.7  0.2 6.9  0.3 0.01 <0.01 0.27
Exercise duration (min) 13.3  0.7 15.7  0.7 12.9  0.4 13.7  0.6 0.15 <0.01 0.04
VO2peak (ml. kg
1 min1) 22.1  1.23 23.3  1.4 23.9  1.4 21.7  1.2 0.87 0.28 0.03
HRpeak (bpm) 149  4 157  5 160  9 157  5 0.60 0.56 0.26
RERpeak 1.14  0.13 1.19  0.06 1.09  0.05 1.18  0.06 0.37 0.01 0.38
Velocity at VT (km. h1) 4.7  0.3 5.4  0.2 4.7  0.2 5.0  0.2 0.99 <0.01 0.98
VO2 at VT (ml. kg
1 min1) 16.4  0.9 16.4  1.1 18.7  0.8 15.6  0.8 0.51 0.06 0.06
%VO2peak at VT 72  1 72  3 75  3 71  2 0.59 0.49 0.52
HR at VT (bpm) 118  4 118  7 117  6 123  6 0.74 0.65 0.19
%HRpeak at VT 80  3 75  3 74  4 78  3 0.53 0.81 0.21
VO2: oxygen uptake, HR: heart rate, RER: respiratory exchange ratio, VT: ventilatory threshold.
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(P < 0.01). While fat free mass remained rather stable in both
groups, fat mass and percentage body fat decreased to a great
extent in TG, but only significant time effects (P < 0.01) were
found for these changes. Regarding lipid profile, a significant
group  time interaction was found for HDLC (P < 0.05), with a
greater increase in control vs trained group. In contrast, both
groups showed lower total cholesterol and LDLC after 12-
weeks, with a significant time effect (P < 0.01) and noFig. 1 – Glycated hemoglobin (HbA1c) at baseline and after
12-weeks in control and trained groups. ANOVA P-values
for group, time and group T time interaction were
respectively 0.23, 0.06 and 0.04.significant changes were found for triglycerides as well as
resting blood pressure (P > 0.05).
Table 2 shows fitness parameters accessed during the
graded exercise tests at baseline and after intervention.
Greater increases in peak treadmill velocity and exercise
duration were observed in the TG, but a significant interaction
was found only for the latter (P < 0.05). A significant group -
 time interaction (P < 0.05) was also observed for VO2peak,
with a 6% increase in the TG but an 8% reduction in the CG. In
addition, while no significant changes were found for HRpeak,
slightly higher respiratory exchange ratio (RER) values in both
groups after 12 weeks led to a significant time effect (P < 0.05).
Regarding submaximal parameters, velocity at VT increased to
a great extent in TG (17 vs 7%), but only significant time effect
(P < 0.01) were found for this change. On the other hand, no
significant main effects or interactions were observed for VT
expressed in physiologic terms (P > 0.05).
Energy intake at baseline, at the 6th week and after the
experimental period in TG and CG were respectively
7569  753 and 7971  791 kJ/day, 6514  506 and
5912  594 kJ/day, and 6828  456 and 5912  414 kJ/day. A
significant time effect (P < 0.05) was found for this variable,
with post-hoc analysis showing lower energy intake at 6th and
12-weeks (P < 0.05) compared to baseline values. On the other
hand, no significant group effect or group  time interaction
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were found for macronutrient composition of the diet (data
not shown).
4. Discussion
The main findings of the present study were that 12-weeks of
supervised walking training at VT velocity led to significant
improvements in long term glycaemic control, body composi-
tion and exercise capacity in middle-aged DM2 women. On the
other hand, such intervention had no significant effects on
fasting blood glucose or lipid profile in these patients.
In line with existing evidence [24], when expressed relative
to VO2peak and HRpeak high inter-individual variability of VT
was observed in our volunteers (60 to 85%), but despite this
intensity has been claimed as a marker for optimal exercise
prescription in DM2 subjects [22–24] to our knowledge this is
the first study addressing the chronic effects of a full
supervised walking program at VT velocity in these patients.
Interestingly, the reduction in Hb1Ac observed in our TG
(11.6%) was greater than those found in the only two previous
studies showing improvements in long term glycaemic control
after walking training in patients with DM2 [7,31]. Walker et al.
[7] showed 12-week of self paced walking for 60 min, five times
a week, to lower HbA1c by 7.6% in postmenopausal DM2
women, while Shenoy et al. [31] found a 9.7% decrease in this
parameter after an 8-week exercise program at 75 to 83%
HRmax for 35 to 40 min, five times a week, in Asian Indians of
both genders with DM2.
Contrary to these studies however, reduced HbA1c in the
present investigation was not accompanied by lower fasting
blood glucose. Given that hemoglobin glycation depends on
mean blood glucose concentration over the 120-day lifespan
of red blood cells [40], this apparently contradictory finding
could result from the acute effects of each exercise bout in
lowering blood glucose. In line with this, Manders et al. [41]
found a single bout of exercise to reduce average blood glucose
concentration and the prevalence of hyperglycemia during the
24-h post exercise period. Mean capillary glycaemia reduction
observed in our subjects in selected training bouts was 27%,
being these values in the adequate range (70–300 mg/dL) for
exercise practice suggested by ADA [39], attesting for the
safety our walking program.
Corroborating previous studies, our results showed walk-
ing training to reduce body mass and BMI in DM2 patients
[7,27–29,31]. In addition, we found a tendency to greater
reduction in fat mass without changes in fat-free mass as a
result of exercise, that also prevented waist circumference
increase, which in turn is strongly related to visceral adipose
tissue, insulin resistance and cardiovascular complications in
DM2 [42–44]. Together, these findings indicate a healthier
anthropometric profile and consequent protection against
obesity related co-morbidities in our subjects after training.
Enhancement on lipid profile including reductions on total
cholesterol and LDLC has been observed in some but not all
walking training studies [7,8,26,27]. Abnormal lipid profile was
observed in our subjects at baseline, however, unexpectedly
changes towards target values were found after experimental
period in both groups. These results may be partiallyexplained by diet characteristics that were not accounted
for in our study protocol, such as reductions in saturated fat,
trans fat and cholesterol intake or also increased viscous fiber
and n-3 fatty acids ingestion [45]. In addition, despite the lack
of significant group or group  time interaction, total energy
intake decreased to a great extent in control vs trained group
through the experimental period (25 vs 10%). This can also
elucidate the greater HDLC increase in control vs trained group
after intervention.
The significant group  time interactions for VO2peak and
exercise duration corroborate data from previous studies [7,30]
and can be considered evidences that our walking training
protocol was able to improve exercise capacity/tolerance in
DM2 subjects. These are relevant adaptations since low
cardiorespiratory fitness is a common feature related to
female gender, family history of coronary heart disease [46]
and an independent predictor of mortality [47] in people with
DM2. Contrary to the hypothesis that training would elicit a
greater increase in VT compared to VO2peak, we found the
former to be unchanged after the intervention when
expressed in physiological terms. In support of this, Larose
et al. [48] observed that workload at VT increased while
%VO2peak at VT remained unchanged after 6-months of
walking and cycling at 60–75% HRmax for 25–45 min, three
times a week in patients with DM2.
Yet regular walking has been considered an interesting
adjunct therapy for DM2 subjects, controversial findings have
been reported regarding the chronic effects of this type of
exercise on health related parameters in such population
[7,8,11,26–31]. These divergences may result from the diversity
of adopted training periods (few weeks up to a year), exercise
frequencies (2–5 days/week), session durations (30–60 min)
and intensities (subjective self paced, brisk walking, %HRmax),
as well as sample characteristics (age, gender, race).
Since our subjects exercised at VT velocities derived from
treadmill tests one could question whether training was
performed at VT intensity expressed in physiological terms
(i.e., %HRpeak or %VO2peak) due to environmental and specifici-
ty concerns. In an attempt to minimize the climatic differ-
ences between laboratory and field conditions, testing and
training sessions were performed at approximately the same
time of the day. In addition, training program was deliberately
conducted during the spring, with rather stable climatic
conditions in our subtropical region. Albeit these cautions do
not warrant identical environments, differences were proba-
bly too small to result in rather discrepant physiological
strains. On the other hand, from the results of Parvataneni
et al. [49] indicating lower metabolic requirement in over-
ground compared to treadmill walking at the same velocity in
older adults, it is plausible that our volunteers’ VT velocity
could be greater if determined on the track. A limitation of the
current investigation however was that we could not quantify
the extent to which overground walking differed from
treadmill walking in physiological terms.
Extending findings from a previous study showing the
feasibility of VT determination during graded treadmill test in
DM2 women [24] we showed overground walking training at
VT velocity to promote a remarkable decrease in HbA1c as well
as improvements in body composition and exercise capacity
in these patients. Importantly, since volunteers presented
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 9 3 ( 2 0 1 1 ) 3 3 7 – 3 4 3342little comorbidity and short disease duration, reaching such
low Hb1Ac values without hypoglycaemia episodes may
provide important reductions in the risk of microvascular
complications [45]. While these results point out the effective-
ness of a field walking program at the laboratory based VT
velocity in DM2 subjects, indices such as the maximal level of
lipid oxidation, which is lower than VT, have been also
suggested for optimizing exercise intensity in patients with
metabolic diseases [50]. Nevertheless, the issue of which
individualized target is more efficient or even whether
individualization is superior than standard procedures for
patients with DM2 is a relatively new research area and further
work on this topic is warranted.
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